Drug Type Small molecule drug |
Synonyms SIR 2446M, SIR2446M |
Mechanism Receptor interacting protein kinase (RIPK) family inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization Sironax Ltd.Startup |
Inactive Organization |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | AU | 17 Dec 2021 | |
Multiple Sclerosis | Phase 1 | AU | 17 Dec 2021 |